July 22, 2025
News oomnia CTMS oomnia eCOA oomnia eConsent oomnia EDC oomnia ePRO oomnia eSource oomnia eTMF oomnia RTSM Clinical data management Biostatistics and programming Trial design and medical writing Large biopharma Emerging biopharma CROs Academia MedTech Nutraceuticals Animal health Food industry Cosmetics Oncology Rare diseases Cardiovascular Neurology / CNS Infectious diseases Immunology Dermatology Gastroenterology Endocrinology Ophthalmology Respiratory

Dr. Nikola Cihoric elected to EUCROF AI Expert Group

We are proud to share that our founder and chief product officer at Wemedoo has been elected as a senior expert in drug development with expertise in Artificial Intelligence by the EUCROF AI Expert Group.

This nomination reflects Dr. Cihoric’s long dedication to advancing digital changes in healthcare and his unique ability to bridge medical science with AI-driven technological innovation.

The EUCROF AI Expert Group unites experts to define how AI is applied in clinical research, an effort Dr. Cihoric supported at the EU Commission’s AI meeting.

His election into this expert body further validates Wemedoo’s vision of building a smarter future for drug development where technology is not just a support tool but a key factor of quality, speed, and patient-centered progress.

Wemedoo thanks to the EUCROF team for their support and transparent collaboration through this process.

The next Full Members’ Board (FMB) meeting is scheduled for Wednesday, 23 July (11:00–13:00 CEST).